OUR PUBLICATIONS
2021
Accelerated phase Ia/b evaluation of the malaria vaccine candidate PfAMA1 DiCo demonstrates broadening of humoral immune responses
Remarque EJ, Faber BW, Rodriguez Garcia R, Oostermeijer H, Sirima SB, Nebie Ouedraogo I, Kara L, Launay O, Houard S, Leroy O, Kocken CHM
NPJ Vaccines. 2021 Apr 14;6(1):55.
2021
Progress and Insights Toward an Effective Placental Malaria Vaccine
Gamain B, Chêne A, Viebig NK, Tuikue Ndam N, Nielsen MA.
Front Immunol. 2021 Feb 25;12:634508.
2020
Animal testing for vaccines. Implementing replacement, reduction and refinement: challenges and priorities
Akkermans A, Chapsal JM, Coccia EM, Depraetere H, Dierick JF, Duangkhae P, Goel S, Halder M, Hendriksen C, Levis R, Pinyosukhee K, Pullirsch D, Sanyal G, Shi L, Sitrin R, Smith D, Stickings P, Terao E, Uhlrich S, Viviani L, Webster J.
iologicals. 2020 Nov;68:92-107.
2020
PRIMVAC vaccine adjuvanted with Alhydrogel or GLA-SE to prevent placental malaria: a first-in-human, randomised, double-blind, placebo-controlled study.
Sirima SB, Richert L, Chêne A, Konate AT, Campion C, Dechavanne S, Semblat JP, Benhamouda N, Bahuaud M, Loulergue P, Ouédraogo A, Nébié I, Kabore M, Kargougou D, Barry A, Ouattara SM, Boilet V, Allais F, Roguet G, Havelange N, Lopez-Perez E, Kuppers A, Konaté E, Roussillon C, Kanté M, Belarbi L, Diarra A, Henry N, Soulama I, Ouédraogo A, Esperou H, Leroy O, Batteux F, Tartour E, Viebig NK, Thiebaut R, Launay O, Gamain B.
Lancet Infect Dis. 2020 May;20(5):585-597.
2020
Epitope Mapping and Fine Specificity of Human T and B Cell Responses for Novel Candidate Blood-Stage Malaria Vaccine P27A.
Geiger KM, Guignard D, Yang C, Bikorimana JP, Correia BE, Houard S, Mkindi C, Daubenberger CA, Spertini F, Corradin G, Audran R.
Front Immunol. 2020 Mar 10;11:412.
2019
Editorial: A Global Perspective on Vaccines: Priorities, Challenges and Online Information.
Tagliabue A, Leite LCC, Leroy OY, Rappuoli R.
Front Immunol. 2019 Nov 12;10:2556.
2019
First-in- human, Randomized, Double-blind Clinical Trial of Differentially Adjuvanted PAMVAC, A Vaccine Candidate to Prevent Pregnancy-associated Malaria.
Mordmüller B, Sulyok M, Egger-Adam D, Resende M, de Jongh WA, Jensen MH, Smedegaard HH, Ditlev SB, Soegaard M, Poulsen L, Dyring C, Calle CL, Knoblich A, Ibáñez J, Esen M, Deloron P, Ndam N, Issifou S, Houard S, Howard RF, Reed SG, Leroy O, Luty AJF, Theander TG, Kremsner PG, Salanti A, Nielsen MA.
Clin Infect Dis. 2019 Oct 15;69(9):1509-1516.
2019
The adjuvant GLA-SE promotes human Tfh cell expansion and emergence of public TCRβ clonotypes.
Hill DL, Pierson W, Bolland DJ, Mkindi C, Carr EJ, Wang J, Houard S, Wingett SW, Audran R, Wallin EF, Jongo SA, Kamaka K, Zand M, Spertini F, Daubenberger C, Corcoran AE, Linterman MA.
J Exp Med. 2019 Aug 5;216(8):1857-1873.
2019
Pipeline analysis of a vaccine candidate portfolio for diseases of poverty using the Portfolio-To-Impact modelling tool.
Gunn A, Bandara S, Yamey G, D Alessio F, Depraetere H, Houard S, Viebig NK, Jungbluth S.
F1000Res. 2019 Jul 11;8:1066
2019
Preclinical immunogenicity and safety of the cGMP-grade placental malaria vaccine PRIMVAC.
Chêne A, Gangnard S, Guadall A, Ginisty H, Leroy O, Havelange N, Viebig NK, Gamain B.
EBioMedicine. 2019 Apr;42:145-156.